Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Blog · Consumer · Published 2026-08-09

Switching Compounded GLP-1 Providers Mid-Treatment: The Handoff Checklist

Switching compounded GLP-1 programs mid-treatment is routine — but only clean when four things are handled in order. Records first: before cancelling anything, download or request your current dose, titration history, last-fill date, and any labs from the outgoing program. Timing second: start the new program's intake while you still have two to three weeks of medication, because evaluation, prescription routing, and cold-chain shipping consume days — a gap in therapy is the most common switching cost. Money third: read the outgoing program's cancellation and refund terms against your plan type; prepaid terms and memberships fail differently. Continuity fourth: your new prescriber sets the dose — bring the history, expect them to continue or step conservatively, and never bridge with doubled orders or leftover-vial improvisation.

The traps that make switches expensive

Four recur in complaint patterns. Cancelling before the replacement is live (the therapy gap, with the regain physiology waiting behind it). Prepaid-term forfeiture — a "12-month price" exited in month three returns money only per the contract, which is why our prepaid analysis treats refund language as part of the price. Auto-renewal overlap — the old subscription billing once more during the handoff; cancel in writing, keep the confirmation. And concentration whiplash: the new pharmacy's vials may carry a different mg/mL, so the label-math routine is mandatory on the first new shipment, not optional.

Choosing the destination like the database does

A switch is a fresh purchase, so the full pre-purchase set applies: effective monthly cost at your dose (not the teaser tier — see dose surcharges), the dispensing pharmacy's name run through the verification workflow, shipment cadence versus beyond-use dates, and written renewal terms. The comparison tool puts up to four programs on identical math, and the August price check shows the current captured field. Switching for $20/month is rational exactly when the handoff costs less than the savings — this checklist is how it does.

Frequently asked questions

Can I switch compounded GLP-1 providers without restarting titration?

Often yes — the new prescriber decides based on your documented history, typically continuing your dose or stepping conservatively. Bring records; never self-bridge with doubled orders.

When should I cancel my old GLP-1 program?

After the new program's first shipment is confirmed — cancelling first creates a therapy gap. Cancel in writing, keep confirmation, and watch for one final auto-renewal billing.

Will I lose money on a prepaid plan if I switch?

Possibly — refunds follow the contract, not fairness. Read the refund terms before switching (ideally before ever prepaying); forfeiture risk is part of any prepaid plan's true price.

Primary sources

This checklist synthesizes the site's captured plan-term data and published cancellation policies; per-program terms are itemized on provider profiles and in the evidence ledger.

Written by

Compounded GLP-1 Guide editorial team
Consumer-focused coverage of the compounded GLP-1 market: pricing capture, plan-structure analysis, and regulatory tracking, published under the site's editorial standards.

Pricing fact-checked

Figures are captured from provider plan pages and primary documents on the dates shown, normalized to effective monthly cost, and carry per-figure evidence status in the evidence ledger.

Medical review

Clinical statements are sourced to FDA labeling, agency communications, and published trial results cited in each article. Named-reviewer sign-off is pending per the methodology — this site does not list a reviewer it doesn't have.

Independent & transparent

Independently operated by US Peptides Partners LLC. Rankings are editorial, computed from published pricing under the methodology, and are not for sale. Outbound provider links carry referral-tracking tags; no arrangement changes a ranking — if a provider out-scores the current leader on captured figures, the ranking changes.